Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy and tolerability of ecopipam
in reducing stuttering symptoms.
It is hypothesized that ecopipam effectively reduces stuttering symptoms as measured on the
SSI-IV total score, the CGI, SSS and OASES.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Gerald Maguire, MD
Collaborator:
University of California Riverisde School of Medicine